166 results on '"Hainque, Elodie"'
Search Results
2. Development and validation of the DBS-PS (Deep Brain Stimulation-Perception Scale): Assessing parkinsonian patients' expectations to prevent post-operative disappointment?
- Author
-
Meyer, Mylène, Spitz, Elisabeth, Colnat-Coulbois, Sophie, Benatru, Isabelle, Guehl, Dominique, Hainque, Elodie, Rolland, Anne-Sophie, Corvol, Jean-Christophe, Devilliers, Hervé, Schwan, Raymund, and Devos, David
- Published
- 2024
- Full Text
- View/download PDF
3. Sustained reduction of essential tremor with low-power non-thermal transcranial focused ultrasound stimulations in humans
- Author
-
Bancel, Thomas, Béranger, Benoît, Daniel, Maxime, Didier, Mélanie, Santin, Mathieu, Rachmilevitch, Itay, Shapira, Yeruham, Tanter, Mickael, Bardinet, Eric, Fernandez Vidal, Sara, Attali, David, Galléa, Cécile, Dizeux, Alexandre, Vidailhet, Marie, Lehéricy, Stéphane, Grabli, David, Pyatigorskaya, Nadya, Karachi, Carine, Hainque, Elodie, and Aubry, Jean-François
- Published
- 2024
- Full Text
- View/download PDF
4. Freezing of gait depends on cortico-subthalamic network recruitment following STN-DBS in PD patients
- Author
-
Temiz, Gizem, Santin, Marie des Neiges, Olivier, Claire, Collomb-Clerc, Antoine, Fernandez-Vidal, Sara, Hainque, Elodie, Bardinet, Eric, Lau, Brian, François, Chantal, Karachi, Carine, and Welter, Marie-Laure
- Published
- 2022
- Full Text
- View/download PDF
5. Personality assessment with Temperament and Character Inventory in Parkinson's disease
- Author
-
Moreau, Caroline, Defebvre, Pr Luc, Carriere, Dr Nicolas, Grolez, Dr Guillaume, Baille, Dr Guillaume, Kreisler, Dr, Jean-Pierre Pruvo, Pr, Leclerc, Pr, Lopes, Dr Renaud, Viard, Dr Romain, Kuchcinski, Dr Gregory, Dumont, Mr Julien, Dujardin, Pr Kathy, Delliaux, Mme M., Brion, Mrs M., Touzet, Dr Gustavo, Reyns, Pr Nicolas, Delval, Pr Arnaud, Santraine, Mrs Valerie, Pleuvret, Mrs Marie, Dautrevaux, Mrs Nolwen, Laugeais, Mr Victor, Ouk, Thavarak, Potey, Camille, Leclercq, Celine, Gers, Elise, Corvol, Jean-Christophe, Marie-Vidailhet, Hainque, Elodie, Welter, Marie-Laure, Lacomblez, Lucette, Grabli, David, Roze, Emmanuel, Worbe, Yulia, Delorme, Cécile, You, Hana, Ihle, Jonas, Guimeraes-Costa, Raquel, Cormier-Dequaire, Florence, Méneret, Aurélie, Hartmann, Andréas, Mariani, Louise-Laure, Lehericy, Stéphane, Czernecki, Virginie, Pineau, Fanny, Bozon, Frédérique, Huiban, Camille, Benchetrit, Eve, Karachi, Carine, Navarro, Soledad, Cornu, Philippe, Welaratne, Arlette, Dongmo-Kenfack, Carole, Mantisi, Lise, Jarry, Nathalie, Aix, Sophie, Lefort, Carine, Rouaud, Dr Tiphaine, Damier, Pr Philippe, Derkinderen, Pr Pascal, Anne-Gaelle Corbille, Dr, Calvier-Auffray, Dr Elisabeth, Rocher, Mrs Laetitia, Anne-Laure Deruet, Mrs, Sylvie, Dr Raoul, Vincent, Dr Roualdes, Le Dily Séverine, Mrs, Marques, Dr Ana, Debilly, Dr Berangere, Durif, Pr Franck, Derost, Dr Philippe, Beal, Dr Charlotte, Chassain, Carine, Delaby, Laure, Vidal, Tiphaine, Jacques Lemaire, Pr Jean, Rieu, Isabelle, Durand, Elodie, Eusebio, Pr Alexandre, Jean-Philippe Azulay, Pr, Witjas, Dr Tatiana, Fluchère, Dr Frédérique, Grimaldi, Dr Stephan, Girard, Pr Nadine, Delfini, Marie, Carron, Dr Romain, Regis, Pr Jean, Spatola, Dr Giorgio, Magnaudet, Camille, Solène, Dr Ansquer, Isabelle, Dr Benatru, Olivier, Dr Colin, Houeto Jl, Pr, Remy, Pr Guillevin, Anne, Mrs Fradet, Manssouri, Mrs Anziza, Sophie, Mrs Blondeau, Philippe, Dr Richard, Philippe, Dr Cam, Philippe, Dr Page, Benoit, Pr Bataille, Emilie, Mrs Rabois, Annie, Mrs Guillemain, Sophie, Dr Drapier, Leh, Dr Frédérique, Bonnet, Dr Alexandre, Vérin, Pr Marc, Jean-Christophe Ferré, Dr, François Houvenaghel, Mr Jean, Haegelen, Pr Claire, Kestens, Mrs Francoise, Ory, Mrs Solenn, Burbaud, Pr Pierre, Damon-Perriere, Dr Nathalie, Meissner, Pr Wassilios, Tison, Pr Francois, Bannier, Dr Stéphanie, Krim, Dr Elsa, Guehl, Pr Dominique, Molinier-Blossier, Sandrine, Ollivier, Morgan, Lacoste, Marion, Auzou, Nicolas, Bonnet, Marie, Cuny, Pr Emmanuel, Engelhardt, Dr Julien, Branchard, Olivier, Huet, Clotilde, Blanchard, Julie, Olivier, Pr Rascol, Brefel Courbon, Dr Christine, Ory Magne, Dr Fabienne, Simonetta Moreau, Dr Marion, Arbus, Pr Christophe, Bonneville, Pr Fabrice, Albert Lotterie, Dr Jean, Sarrail, Marion, Scotto d’Apollonia, Charlotte, Chaynes, Pr Patrick, Caire, Pr François, Harroch, Estelle, Maltete, Pr David, Lefaucheur, Dr Romain, Fetter, Dr Damien, Magne, Dr Nicolas, Bioux, Mrs Sandrine, Loubeyre, Mrs Maud, Bliaux, Mrs Evangéline, Pouliquen, Mrs Dorothée, Derrey, Pr Stéphane, Vernon, Mrs Linda, Ziegler, Dr Frédéric, Anheim, Mathieu, Lagha-Boukbiza, Ouhaid, Tranchant, Christine, Gebus, Odile, Montaut, Solveig, Kremer, S., Longato, Nadine, Phillips, Clélie, Voirin, Jimmy, Santin, Marie des Neiges, Chaussemy, Dominique, Mengin, Dr Amaury, Giordana, Dr Caroline, Marsé, Dr Claire, Mondot, Lydiane, Giordana, Bruno, Kardous, Robin, Bailet, Bernadette, Joly, Héloise, Fontaine, Denys, Leplus, Dr Aurélie, Faustini, Amélie, Ferrier, Vanessa, Krystkowiak, Pr Pierre, Tir, Dr Mélissa, Jean-Marc Constans, Pr, Wannepain, Sandrine, Seling, Audrey, Lefranc, Dr Michel, Blin, Stéphanie, Schuler, Béatrice, Thobois, Pr Stephane, Danaila, Dr Teodor, Laurencin, Dr Chloe, Berthezene, Pr Yves, Ameli, Dr Roxana, Klinger, Helene, Polo, Dr Gustavo, Mertens, Patrick, Nunes, A., Metereau, Elise, Hopes, Dr Lucie, Frismand, Dr Solène, Schmitt, Dr Emmanuelle, Meyer, Mrs Mylène, Dillier, Mrs Céline, Colnat, Pr Sophie, Chatelain, Mrs Anne, Philippe Brandel, Dr Jean, Hubsch, Dr Cécile, Karsenti, Dr Patte, Lebouteux, Dr Marie, Ziegler, Dr Marc, Delmaire, Dr Christine, Savatowky, Dr Julien, Vrillac, Mrs Juliette, Nakache, Mrs Claire, D'Hardemare, Dr Vincent, Belamri, Mr Lhaouas, Mesnage, Dr Valérie, Bonnet, Dr Cécilia, Correa Lino, Dr Jarbas, Jr., Decrocq, Dr Camille, Boulin, Dr Anne, Barre, Mrs Inès, Manouvrier, Mrs Jordane, Gardel, Dr Bérénice, Jarraya, Pr Béchir, Ziz, Mrs Catherine, Prette, Mrs Lydie, Douzane, Mr Hassen, Gay, David, Bonicel, Robin, El Mountassir, Fouzia, Fischer, Clara, Mangin, Jean-François, Chupin, Marie, Cointepas, Yann, Accart, Bertrand, Gelé, Patrick, Fievet, Florine, Chabel, Matthieu, Derenaucourt, Virginie, Facon, Loïc, Njosse, Yanick Tchantchou, Deplanque, Dominique, Duhamel, Alain, Djemmane, Lynda, Duflot, Florence, Boussac, Mathilde, Arbus, Christophe, Colin, Olivier, Laurencin, Chloé, Eusebio, Alexandre, Corvol, Jean Christophe, Versace, Nathalie, Rascol, Olivier, Rousseau, Vanessa, Ory-Magne, Fabienne, Fabbri, Margherita, Rolland, Anne-Sophie, Jarraya, Béchir, Maltête, David, Drapier, Sophie, Marques, Ana-Raquel, Wirth, Thomas, Meyer, Mylène, Tir, Mélissa, Rouaud, Tiphaine, Devos, David, and Brefel-Courbon, Christine
- Published
- 2022
- Full Text
- View/download PDF
6. Directional Subthalamic Deep Brain Stimulation Better Improves Gait and Balance Disorders in Parkinson's Disease Patients: A Randomized Controlled Study.
- Author
-
Cherif, Saoussen, Tempier, Nicolas, Yeche, Mathieu, Temiz, Gizem, Perrière, Julia, Romanato, Marco, Ziri, Déborah, Fernandez‐Vidal, Sara, Hainque, Elodie, Maltête, David, Derrey, Stéphane, Bardinet, Eric, Lau, Brian, Karachi, Carine, and Welter, Marie‐Laure
- Subjects
DEEP brain stimulation ,GAIT disorders ,PARKINSON'S disease ,BALANCE disorders ,CONTRAST effect ,BRAIN stimulation - Abstract
Objective: To investigate the effects of directional subthalamic deep brain stimulation (STN‐dDBS) on gait and balance disorders, including freezing of gait (FOG), in patients with advanced Parkinson's disease (PD). Methods: We included 10 participants who underwent STN‐DBS and presented severe preoperative FOG, in a randomized, double‐blind, crossover study. We used segmented DBS electrodes to investigate whether directing the predicted volume of tissue activated (VTA) to overlap the central STN preferentially improved gait and balance disorders compared to directional DBS applied in the more posterior STN (sensorimotor). We also assessed non‐directional (ring‐mode) STN‐DBS. Our primary outcome was gait and balance control measured using instrumented gait recordings. Each patient had a pre‐operative structural and diffusion‐weighted imaging to model individual VTAs and to examine cortico‐subthalamic connectivity. We used linear mixed‐effects models to contrast the effects of central STN‐dDBS, posterior STN‐dDBS, and ring‐mode STN‐DBS. Results: Central STN‐dDBS produced significantly better improvement in gait and balance control compared to posterior STN‐dDBS (p = 0.027), with fewer FOG episodes (p < 0.001). Conversely, ring‐mode STN‐DBS resulted in worsened postural control compared to central STN‐dDBS (p = 0.009). The cortico‐subthalamic connectivity with the STN VTAs involved mostly primary sensorimotor, premotor, and medial frontal cortices, with a higher overall cortico‐STN connectivity with ring‐mode STN‐DBS. Interpretation: Central STN‐dDBS represents the best option to improve gait and balance disorders in PD patients, including FOG. Our findings raise the possibility of reprogramming STN‐DBS toward the central area in selected patients with disabling FOG and/or postural instability after surgery. ANN NEUROL 2025;97:149–162 [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF
7. Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
- Author
-
Meira, Bruna, Degos, Bertrand, Corsetti, Elise, Doulazmi, Mohamed, Berthelot, Emeline, Virbel-Fleischman, Clara, Dodet, Pauline, Méneret, Aurélie, Mariani, Louise-Laure, Delorme, Cécile, Cormier-Dequaire, Florence, Bendetowicz, David, Villain, Nicolas, Tarrano, Clément, Mantisi, Lise, Letrillart, Hélène, Louapre, Céline, McGovern, Eavan, Worbe, Yulia, Grabli, David, Vidailhet, Marie, Hainque, Elodie, and Roze, Emmanuel
- Published
- 2021
- Full Text
- View/download PDF
8. Atypical ADCY5-related movement disorders: Highlighting adolescent/adult-onset cervical dystonia
- Author
-
Quazza, Floriane, Riant, Florence, Patera, Martina, Suppa, Antonio, Satolli, Sara, Burglen, Lydie, Zech, Michael, Boesch, Sylvia, Indelicato, Elisabetta, Hainque, Elodie, Apartis, Emmanuelle, Rodriguez, Diana, Doummar, Diane, Méneret, Aurélie, and Ravelli, Claudia
- Published
- 2025
- Full Text
- View/download PDF
9. ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson’s disease.
- Author
-
Faggianelli, Florent, Witjas, Tatiana, Azulay, J-P., Benatru, Isabelle, Hubsch, Cécile, Anheim, Mathieu, Moreau, Caroline, Hainque, Elodie, Drapier, Sophie, Jarraya, Béchir, Laurencin, Chloé, Guehl, Dominique, Hopes, Lucie, Brefel-Courbon, Christine, Tir, Melissa, Marques, Ana, Rouaud, Tiphaine, Maltete, David, Giordana, Caroline, and Baumstarck, Karine
- Subjects
PARKINSON'S disease ,NEUROLEPTIC malignant syndrome ,MOVEMENT disorders ,RESTLESS legs syndrome ,DEEP brain stimulation - Published
- 2024
- Full Text
- View/download PDF
10. New insight in spiral drawing analysis methods – Application to action tremor quantification
- Author
-
Legrand, André Pierre, Rivals, Isabelle, Richard, Aliénor, Apartis, Emmanuelle, Roze, Emmanuel, Vidailhet, Marie, Meunier, Sabine, and Hainque, Elodie
- Published
- 2017
- Full Text
- View/download PDF
11. Can Dopamine Responsiveness Be Predicted in Parkinson’s Disease Without an Acute Administration Test?
- Author
-
Betrouni, Nacim, Moreau, Caroline, Rolland, Anne-Sophie, Carrière, Nicolas, Viard, Romain, Lopes, Renaud, Kuchcinski, Gregory, Eusebio, Alexandre, Thobois, Stephane, Hainque, Elodie, Hubsch, Cecile, Rascol, Olivier, Brefel, Christine, Drapier, Sophie, Giordana, Caroline, Durif, Franck, Maltête, David, Guehl, Dominique, Hopes, Lucie, Rouaud, Tiphaine, Jarraya, Bechir, Benatru, Isabelle, Tranchant, Christine, Tir, Melissa, Chupin, Marie, Bardinet, Eric, Defebvre, Luc, Corvol, Jean-Christophe, Devos, David, Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), École des Hautes Études en Santé Publique [EHESP] (EHESP), CHU Lille, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Plateformes Lilloises en Biologie et Santé - UAR 2014 - US 41 (PLBS), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), CHU Marseille, CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Hôpital de la Fondation Ophtalmologique Adolphe de Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Service de Neurologie [CHU Nice], Hôpital Pasteur [Nice] (CHU)-Centre Hospitalier Universitaire de Nice (CHU Nice), CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Différenciation et communication neuronale et neuroendocrine (DC2N), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Rouen, Normandie Université (NU), CHU Bordeaux [Bordeaux], Service de neurologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Amiens-Picardie, Laboratoire de Neurosciences Fonctionnelles et Pathologies - UR UPJV 4559 (LNFP), and Université de Picardie Jules Verne (UPJV)
- Subjects
Antiparkinson Agents ,Levodopa ,Cellular and Molecular Neuroscience ,Dopamine ,[SCCO.NEUR]Cognitive science/Neuroscience ,Humans ,Parkinson Disease ,Neurology (clinical) ,Magnetic Resonance Imaging - Abstract
Background: Dopamine responsiveness (dopa-sensitivity) is an important parameter in the management of patients with Parkinson’s disease (PD). For quantification of this parameter, patients undergo a challenge test with acute Levodopa administration after drug withdrawal, which may lead to patient discomfort and use of significant resources. Objective: Our objective was to develop a predictive model combining clinical scores and imaging. Methods: 350 patients, recruited by 13 specialist French centers and considered for deep brain stimulation, underwent an acute L-dopa challenge (dopa-sensitivity > 30%), full assessment, and MRI investigations, including T1w and R2* images. Data were randomly divided into a learning base from 10 centers and data from the remaining centers for testing. A machine selection approach was applied to choose the optimal variables and these were then used in regression modeling. Complexity of the modelling was incremental, while the first model considered only clinical variables, the subsequent included imaging features. The performances were evaluated by comparing the estimated values and actual values Results: Whatever the model, the variables age, sex, disease duration, and motor scores were selected as contributors. The first model used them and the coefficients of determination (R2) was 0.60 for the testing set and 0.69 in the learning set (p
- Published
- 2022
- Full Text
- View/download PDF
12. Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.
- Author
-
Béreau, Matthieu, Kibleur, Astrid, Servant, Mathieu, Clément, Gautier, Dujardin, Kathy, Rolland, Anne-Sophie, Wirth, Thomas, Lagha-Boukbiza, Ouhaid, Voirin, Jimmy, Santin, Marie des Neiges, Hainque, Elodie, Grabli, David, Comte, Alexandre, Drapier, Sophie, Durif, Franck, Marques, Ana, Eusebio, Alexandre, Azulay, Jean-Philippe, Giordana, Caroline, and Houeto, Jean-Luc
- Subjects
APATHY ,SUBTHALAMIC nucleus ,PARKINSON'S disease ,DEEP brain stimulation ,EXECUTIVE function ,EPISODIC memory ,MOTIVATION (Psychology) - Abstract
Postoperative apathy is a frequent symptom in Parkinson's disease patients who have undergone bilateral deep brain stimulation of the subthalamic nucleus. Two main hypotheses for postoperative apathy have been suggested: (i) dopaminergic withdrawal syndrome relative to postoperative dopaminergic drug tapering; and (ii) direct effect of chronic stimulation of the subthalamic nucleus. The primary objective of our study was to describe preoperative and 1-year postoperative apathy in Parkinson's disease patients who underwent chronic bilateral deep brain stimulation of the subthalamic nucleus. We also aimed to identify factors associated with 1-year postoperative apathy considering: (i) preoperative clinical phenotype; (ii) dopaminergic drug management; and (iii) volume of tissue activated within the subthalamic nucleus and the surrounding structures. We investigated a prospective clinical cohort of 367 patients before and 1 year after chronic bilateral deep brain stimulation of the subthalamic nucleus. We assessed apathy using the Lille Apathy Rating Scale and carried out a systematic evaluation of motor, cognitive and behavioural signs. We modelled the volume of tissue activated in 161 patients using the Lead-DBS toolbox and analysed overlaps within motor, cognitive and limbic parts of the subthalamic nucleus. Of the 367 patients, 94 (25.6%) exhibited 1-year postoperative apathy: 67 (18.2%) with ' de novo apathy' and 27 (7.4%) with 'sustained apathy'. We observed disappearance of preoperative apathy in 22 (6.0%) patients, who were classified as having 'reversed apathy'. Lastly, 251 (68.4%) patients had neither preoperative nor postoperative apathy and were classified as having 'no apathy'. We identified preoperative apathy score [odds ratio (OR) 1.16; 95% confidence interval (CI) 1.10, 1.22; P < 0.001], preoperative episodic memory free recall score (OR 0.93; 95% CI 0.88, 0.97; P = 0.003) and 1-year postoperative motor responsiveness (OR 0.98; 95% CI 0.96, 0.99; P = 0.009) as the main factors associated with postoperative apathy. We showed that neither dopaminergic dose reduction nor subthalamic stimulation were associated with postoperative apathy. Patients with 'sustained apathy' had poorer preoperative fronto-striatal cognitive status and a higher preoperative action initiation apathy subscore. In these patients, apathy score and cognitive status worsened postoperatively despite significantly lower reduction in dopamine agonists (P = 0.023), suggesting cognitive dopa-resistant apathy. Patients with 'reversed apathy' benefited from the psychostimulant effect of chronic stimulation of the limbic part of the left subthalamic nucleus (P = 0.043), suggesting motivational apathy. Our results highlight the need for careful preoperative assessment of motivational and cognitive components of apathy as well as executive functions in order to better prevent or manage postoperative apathy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease: ADAPT-PD clinical trial methodology and early data (P1-11.002)
- Author
-
Bronte-Stewart, Helen, primary, Beudel, Martijn, additional, Ostrem, Jill L., additional, Fasano, Alfonso, additional, Almeida, Leonardo, additional, Hassell, Travis, additional, Moro, Elena, additional, Gostkowski, Michal, additional, Mitchell, Kyle T., additional, Hainque, Elodie, additional, Sarangmat, Nagaraja, additional, Stanslaski, Scott, additional, Tonder, Lisa, additional, Summers, Rebekah, additional, Raike, Robert S., additional, and Herrington, Todd M., additional
- Published
- 2023
- Full Text
- View/download PDF
14. Deep brain stimulation and dopamine medication enhance free choice preference in Parkinson’s disease
- Author
-
Bendetowicz, David, primary, Temiz, Gizem, additional, Hainque, Elodie, additional, Czernecki, Virginie, additional, Lau, Brian, additional, Karachi, Carine, additional, and Munuera, Jérôme, additional
- Published
- 2023
- Full Text
- View/download PDF
15. Teaching Video NeuroImages: A syndrome of pathologic startle responses
- Author
-
Mariani, Louise-Laure, Hainque, Elodie, Mongin, Marie, Apartis, Emmanuelle, and Roze, Emmanuel
- Published
- 2017
- Full Text
- View/download PDF
16. Biomechanical Upper Limb Model for Postural Tremor Absorber Design
- Author
-
Gebai, Sarah, primary, Cumunel, Gwendal, additional, Hammoud, Mohammad, additional, Foret, Gilles, additional, Roze, Emmanuel, additional, and Hainque, Elodie, additional
- Published
- 2022
- Full Text
- View/download PDF
17. Comment to: "Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome–Associated Paroxysmal Movement Disorders".
- Author
-
Roze, Emmanuel, Méneret, Aurélie, Hainque, Elodie, and Mochel, Fanny
- Published
- 2024
- Full Text
- View/download PDF
18. Design and Simulation of a Passive Absorber to Reduce Measured Postural Tremor Signal
- Author
-
Gebai, Sarah, primary, Cumunel, Gwendal, additional, Hammoud, Mohammad, additional, Foret, Gilles, additional, Roze, Emmanuel, additional, and Hainque, Elodie, additional
- Published
- 2022
- Full Text
- View/download PDF
19. Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson’s Disease (PSYCHO-STIM II)
- Author
-
Boussac, Mathilde, Arbus, Christophe, Klinger, Helene, Eusebio, Alexandre, Hainque, Elodie, Christophe Corvol, Jean, Rascol, Olivier, Rousseau, Vanessa, Harroch, Estelle, D’apollonia, Charlotte Scotto, Croiset, Aurélie, Ory-Magne, Fabienne, de Barros, Amaury, Fabbri, Margherita, Moreau, Caroline, Rolland, Anne-Sophie, Benatru, Isabelle, Anheim, Mathieu, Marques, Ana-Raquel, Maltête, David, Drapier, Sophie, Jarraya, Béchir, Hubsch, Cécile, Guehl, Dominique, Meyer, Mylène, Rouaud, Tiphaine, Giordana, Bruno, Tir, Mélissa, Devos, David, Brefel-Courbon, Christine, Toulouse Neuro Imaging Center (ToNIC), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Toulouse Mind & Brain Institut (TMBI), Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Hospices Civils de Lyon, Departement de Neurologie (HCL), Hôpital de la Timone [CHU - APHM] (TIMONE), Institut de Neurosciences de la Timone (INT), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre d’Excellence en Maladies Neurodégénératives (NeuroToul), CIC - Biotherapie - Toulouse, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d’Etudes et de Recherches en Psychopathologie et Psychologie de la Santé (CERPPS), Université de Toulouse (UT)-Université de Toulouse (UT)-Toulouse Mind & Brain Institut (TMBI), Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CIC - Poitiers, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre for Integrative Biology - CBI (Inserm U964 - CNRS UMR7104 - IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut national polytechnique Clermont Auvergne (INP Clermont Auvergne), Université Clermont Auvergne (UCA), Institut Pascal (IP), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA)-Institut national polytechnique Clermont Auvergne (INP Clermont Auvergne), Université Clermont Auvergne (UCA)-Université Clermont Auvergne (UCA), Différenciation et communication neuronale et neuroendocrine (DC2N), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Neuroimagerie cognitive - Psychologie cognitive expérimentale (UNICOG-U992), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Hôpital de la Fondation Ophtalmologique Adolphe de Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Bordeaux [Bordeaux], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Hôpital Guillaume-et-René-Laennec [Saint-Herblain], Centre Hospitalier Universitaire de Nice (CHU Nice), Laboratoire de Neurosciences Fonctionnelles et Pathologies - UR UPJV 4559 (LNFP), Université de Picardie Jules Verne (UPJV), The study was funded by the France Parkinson charity and French Ministry of Health (PHRC national 2012). This is an ancillary study to Protocol ID: 2013-A00193-42, ClinicalTrials.gov:NCT02360683., Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], CHU Toulouse [Toulouse], Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Lille Neurosciences & Cognition - U 1172 (LilNCog (ex-JPARC)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Saclay (COmUE)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de Neurosciences Fonctionnelles et Pathologies, Université de Picardie Jules Verne (UPJV)-Université Lille 2 - Faculté de Médecine -Université Charles de Gaulle - Lille 3, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), and Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Saclay (COmUE)
- Subjects
Deep Brain Stimulation ,[SDV]Life Sciences [q-bio] ,novelty seeking ,Parkinson Disease ,DBS-STN ,humanities ,030227 psychiatry ,nervous system diseases ,Cohort Studies ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,surgical procedures, operative ,nervous system ,quality of life ,Subthalamic Nucleus ,Parkinson’s disease ,Humans ,Cooperativeness ,Neurology (clinical) ,therapeutics ,030217 neurology & neurosurgery ,Personality - Abstract
International audience; BACKGROUND: Deep brain stimulation of the sub-thalamic nucleus (DBS-STN) reduces symptoms in Parkinson’s disease (PD) patients with motor fluctuations. However, some patients may not feel ameliorated afterwards, despite an objective motor improvement. It is thus important to find new predictors of patients’ quality of life (QoL) amelioration after DBS-STN. We hypothesized that personality dimensions might affect QoL after DBS-STN. OBJECTIVE: To evaluate associations between personality dimensions and QoL improvement one year after DBS-STN. METHODS: DBS-STN-PD patients (n = 303) having answered the "Temperament and Character Inventory" (TCI) before surgery and the PDQ-39 before and one year after surgery were included, from the cohort study PREDI-STIM. Linear regression models were used to evaluate associations between TCI dimensions and change in PDQ-39 scores after DBS-STN. RESULTS: Novelty Seeking and Cooperativeness scores before surgery were positively associated with PDQ-39 scores improvement after DBS-STN (FDR-adjusted p < 0.01). Moreover, paradoxically unimproved patients with deterioration of their PDQ-39 scores after DBS-STN despite improvement of their MDS-UPDRS-IV scores had lower Cooperativeness scores, while paradoxically improved patients with amelioration of their PDQ-39 scores despite deterioration of their MDS-UPDRS-IV scores had higher Reward Dependence scores. CONCLUSION: Some presurgical personality dimensions were significantly associated with QoL amelioration and discrepancy between motor state and QoL changes after DBS-STN in PD. Educational programs before DBS-STN should take in account patient personality dimensions to better deal with their expectations.
- Published
- 2022
- Full Text
- View/download PDF
20. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
- Author
-
Mochel, Fanny, Hainque, Elodie, Gras, Domitille, Adanyeguh, Isaac M, Caillet, Samantha, Héron, Bénédicte, Roubertie, Agathe, Kaphan, Elsa, Valabregue, Romain, Rinaldi, Daisy, Vuillaumier, Sandrine, Schiffmann, Raphael, Ottolenghi, Chris, Hogrel, Jean-Yves, Servais, Laurent, and Roze, Emmanuel
- Published
- 2016
- Full Text
- View/download PDF
21. Upper limb involuntary tremor reduction using cantilever beam TMDs
- Author
-
Gebai, Sarah, primary, Cumunel, Gwendal, additional, Hammoud, Mohammad, additional, Foret, Gilles, additional, Roze, Emmanuel, additional, and Hainque, Elodie, additional
- Published
- 2022
- Full Text
- View/download PDF
22. Upper limb involuntary tremor reduction using cantilever beam TMDs.
- Author
-
Gebai, Sarah, Cumunel, Gwendal, Hammoud, Mohammad, Foret, Gilles, Roze, Emmanuel, and Hainque, Elodie
- Subjects
TUNED mass dampers ,WRIST joint ,TREMOR ,CANTILEVERS ,ROTATIONAL motion ,WRIST - Abstract
Tuned mass dampers (TMDs) are proposed as a solution to reduce the involuntary tremor at the upper limb of a patient with postural tremor. The upper limb is modeled as a three-degrees-of-freedom rotating system in the vertical plane, with a flexion-extension motion at the joints. The measured extensor carpi radialis signal of a patient is used to excite the dynamic model. We propose a numerical methodology to optimize the parameters of the TMDs in the frequency domain combined with the response in the time domain. The objective function for the optimization of the dynamic problem is the maximum angular displacement of the wrist joint. The optimal stiffness and damping of the TMDs are obtained by satisfying the minimization of the selected objective function. The considered passive absorber is a cantilever beam–like TMD, whose length, beam cross-sectional diameter, and mass position reflect its stiffness for a chosen additional mass. A parametric study of the TMD is conducted to evaluate the effect of the TMD position along the hand segment, the number of TMDs, and the total mass of TMDs. The sensitivity of the TMD to a decrease of its modal damping ratio is studied to meet the range of stainless steel. TMDs are manufactured using stainless steel beams of the same length (9.1 cm) and cross-sectional diameter (0.79 mm), for which the mass (14.13 g) position is adjusted to match the optimal frequency. Three TMDs holding a mass of 14.13 g each cause 89% reduction in the wrist joint angular displacement. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Experimental Testing of Passive Linear TMD for Postural Tremor Attenuation
- Author
-
Gebai, Sarah, primary, Hammoud, Mohammad, additional, Cumunel, Gwendal, additional, Foret, Gilles, additional, Roze, Emmanuel, additional, and Hainque, Elodie, additional
- Published
- 2021
- Full Text
- View/download PDF
24. J01 Triheptanoin is associated with clinical stability and decreased caudate atrophy in huntington disease
- Author
-
Mochel, Fanny, primary, Meneret, Aurélie, additional, Adanyeguh, Isaac, additional, Giron, Camille, additional, Hainque, Elodie, additional, Luton, Marie-Pierre, additional, Atencio, Mariana, additional, Jacobs, Milou, additional, Veldkamp, Fleur, additional, Coppen, Emma, additional, Zwaan, Kasper van der, additional, Vicaut, Eric, additional, Roos, Raymund AC, additional, and Durr, Alexandra, additional
- Published
- 2021
- Full Text
- View/download PDF
25. “Habit” gambling behaviour caused by ischemic lesions affecting the cognitive territories of the basal ganglia
- Author
-
Cognat, Emmanuel, Lagarde, Julien, Decaix, Caroline, Hainque, Elodie, Azizi, Louisa, Gaura-Schmidt, Veronique, Mesnage, Valerie, and Levy, Richard
- Published
- 2010
- Full Text
- View/download PDF
26. Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical Modifications.
- Author
-
Devignes, Quentin, Daoudi, Sami, Viard, Romain, Lopes, Renaud, Betrouni, Nacim, Kuchcinski, Gregory, Rolland, Anne-Sophie, Moreau, Caroline, Defebvre, Luc, Bardinet, Eric, Bonnet, Marie, Brefel-Courbon, Christine, Delmaire, Christine, El Mountassir, Fouzia, Fluchère, Frédérique, Fradet, Anne, Giordana, Caroline, Hainque, Elodie, Houvenaghel, Jean-François, and Jarraya, Béchir
- Subjects
DEEP brain stimulation ,SUBTHALAMIC nucleus ,CAUDATE nucleus ,CEREBRAL cortical thinning ,MILD cognitive impairment ,PARKINSON'S disease - Abstract
Background: Parkinson's disease mild cognitive impairment (PD-MCI) is frequent and heterogenous. There is no consensus about its influence on subthalamic deep brain stimulation (STN-DBS) outcomes. Objective: To determine the prevalence of PD-MCI and its subtypes in candidates to STN-DBS. Secondarily, we sought to identify MRI structural markers associated with cognitive impairment in these subgroups. Methods: Baseline data from the French multicentric PREDISTIM cohort were used. Candidates to STN-DBS were classified according to their cognitive performance in normal cognition (PD-NC) or PD-MCI. The latter included frontostriatal (PD-FS) and posterior cortical (PD-PC) subtypes. Between-group comparisons were performed on demographical and clinical variables as well as on T1-weighted MRI sequences at the cortical and subcortical levels. Results: 320 patients were included: 167 (52%) PD-NC and 153 (48%) PD-MCI patients. The latter group included 123 (80%) PD-FS and 30 (20%) PD-PC patients. There was no between-group difference regarding demographic and clinical variables. PD-PC patients had significantly lower global efficiency than PD-FS patients and significantly worse performance on visuospatial functions, episodic memory, and language. Compared to PD-NC, PD-MCI patients had cortical thinning and radiomic-based changes in the left caudate nucleus and hippocampus. There were no significant differences between the PD-MCI subtypes. Conclusion: Among the candidates to STN-DBS, a significant proportion has PD-MCI which is associated with cortical and subcortical alterations. Some PD-MCI patients have posterior cortical deficits, a subtype known to be at higher risk of dementia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Effect of Triheptanoin on Caudate Atrophy and Motor Scores in Patients With Early-Stage Huntington Disease
- Author
-
Mochel, Fanny, Méneret, Aurélie, Adanyeguh, Isaac M., Giron, Camille, Hainque, Elodie, Luton, Marie-Pierre, Atencio, Mariana, Debs, Rabab, Jacobs, Milou, Veldkamp, Fleur C.M., Barbier, Magali, Coppen, Emma M., van der Zwaan, Kasper F., Diallo, Abdourahmane, Ottolenghi, Chris, Vicaut, Eric, Roos, Raymond A., and Durr, Alexandra
- Published
- 2025
- Full Text
- View/download PDF
28. Impact de la stimulation du noyau sub-thalamique sur les troubles du contrôle des impulsions dans la maladie de Parkinson : pronostic à 1 an et facteurs prédictifs
- Author
-
Santin-Baloglu, Marie Des Neiges, primary, Voulleminot, Paul, additional, Vrillon, Agathe, additional, Hainque, Elodie, additional, Devos, David, additional, Tranchant, Christine, additional, and Anheim, Mathieu, additional
- Published
- 2021
- Full Text
- View/download PDF
29. Prediction of evolution toward brain death upon admission to ICU in comatose patients with spontaneous intracerebral hemorrhage using simple signs
- Author
-
Galbois, Arnaud, Boëlle, Pierre-Yves, Hainque, Elodie, Raynal, Marianne, Cazejust, Julien, Baudel, Jean-Luc, Ait-Oufella, Hafid, Alves, Mikael, Bigé, Naïke, Maury, Eric, Guidet, Bertrand, and Offenstadt, Georges
- Published
- 2013
- Full Text
- View/download PDF
30. Whispering dysphonia in TUBB4A ‐related disorders responsive to bipallidal deep brain stimulation
- Author
-
Delorme, Cécile, primary, Roze, Emmanuel, additional, Karachi, Carine, additional, Vidailhet, Marie, additional, and Hainque, Elodie, additional
- Published
- 2021
- Full Text
- View/download PDF
31. Antisaccade, a predictive marker for freezing of gait in Parkinson’s disease and gait/gaze network connectivity
- Author
-
Gallea, Cécile, primary, Wicki, Benoit, additional, Ewenczyk, Claire, additional, Rivaud-Péchoux, Sophie, additional, Yahia-Cherif, Lydia, additional, Pouget, Pierre, additional, Vidailhet, Marie, additional, and Hainque, Elodie, additional
- Published
- 2020
- Full Text
- View/download PDF
32. Évolution et facteurs prédictifs à court terme des dyskinésies après stimulation cérébrale profonde du noyau sous-thalamique dans la maladie de Parkinson
- Author
-
Vrillon, Agathe, primary, Voulleminot, Paul, additional, Des Neiges Santin-Baloglu, Marie, additional, Kyheng, Maeva, additional, Bardinet, Eric, additional, Hainque, Elodie, additional, and Grabli, David, additional
- Published
- 2020
- Full Text
- View/download PDF
33. Rapid worsening in Parkinson's disease may hide COVID-19 infection
- Author
-
Hainque, Elodie, primary and Grabli, David, additional
- Published
- 2020
- Full Text
- View/download PDF
34. Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery.
- Author
-
Besse-Pinot, Elsa, Pereira, Bruno, Durif, Franck, Fantini, Maria Livia, Durand, Elodie, Debilly, Bérengère, Derost, Philippe, Moreau, Caroline, Hainque, Elodie, Rouaud, Tiphaine, Eusebio, Alexandre, Benatru, Isabelle, Drapier, Sophie, Guehl, Dominique, Rascol, Olivier, Maltête, David, Lagha-Boukbiza, Ouhaïd, Giordana, Caroline, Tir, Melissa, and Thobois, Stéphane
- Published
- 2021
- Full Text
- View/download PDF
35. Analysis of Pathological Tremor Behavior: Application to Design a Passive Tremor Attenuator
- Author
-
GEBAI, SARAH, primary, CUMUNEL, GWENDAL, additional, HAMMOUD, MOHAMMAD, additional, FORET, GILLES, additional, APARTIS, EMMANUELLE, additional, FLAMAND-ROZE, EMMANUEL, additional, and HAINQUE, ELODIE, additional
- Published
- 2019
- Full Text
- View/download PDF
36. Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndrome
- Author
-
Hainque, Elodie, primary, Meneret, Aurélie, additional, Gras, Domitille, additional, Atencio, Mariana, additional, Luton, Marie-Pierre, additional, Barbier, Magali, additional, De Saint Martin, Anne, additional, Billette de Villemeur, Thierry, additional, Ottolenghi, Chris, additional, Roze, Emmanuel, additional, and Mochel, Fanny, additional
- Published
- 2019
- Full Text
- View/download PDF
37. Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect
- Author
-
Hainque, Elodie, primary, Gras, Domitille, additional, Meneret, Aurélie, additional, Atencio, Mariana, additional, Luton, Marie-Pierre, additional, Barbier, Magali, additional, Doulazmi, Mohamed, additional, Habarou, Florence, additional, Ottolenghi, Chris, additional, Roze, Emmanuel, additional, and Mochel, Fanny, additional
- Published
- 2019
- Full Text
- View/download PDF
38. Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.
- Author
-
Santin, Marie des Neiges, Voulleminot, Paul, Vrillon, Agathe, Hainque, Elodie, Béreau, Matthieu, Lagha‐Boukbiza, Ouhaid, Wirth, Thomas, Montaut, Solveig, Bardinet, Eric, Kyheng, Maeva, Rolland, Anne‐Sophie, Voirin, Jimmy, Drapier, Sophie, Durif, Franck, Eusebio, Alexandre, Giordana, Caroline, Auzou, Nicolas, Houeto, Jean‐Luc, Hubsch, Cécile, and Jarraya, Béchir
- Abstract
Background: Impact of subthalamic deep brain stimulation (DBS) on impulse control disorders (ICD) in Parkinson's disease (PD) remains controversial. Objectives: The objectives of this study were to analyze the natural history of ICD between baseline and 1 year after subthalamic DBS in patients with PD and to identify predictive factors, taking into account the positions of the active contact and stimulation parameters. Methods: We analyzed postoperative modifications of ICD based on the multicentric, prospective Predictive Factors and Subthalamic Stimulation in Parkinson's Disease cohort. ICD status and Ardouin Scale of Behaviour in PD were assessed at baseline and 1 year following subthalamic DBS. Location of active contacts within the 3 subthalamic nucleus functional territories was investigated. Results: A total of 217 were patients included. Of the patients, 10.6% had ICD at baseline of which 95.6% improved at 1 year following subthalamic DBS; 3.6% of the patients experienced de novo ICD at 1 year following subthalamic DBS. Dopamine agonist dose reduction (from 309.8 to 109.3 mg) was the main driver of ICD regression (P = 0.05). Higher preoperative dyskinesias were associated with poorer ICD evolution (P = 0.04). Whereas baseline apathy was a risk factor of de novo ICD (P = 0.02), ICD improvement correlated with postoperative apathy (P = 0.004). Stimulation power and position of active contacts—mainly located within the sensorimotor part of the subthalamic nucleus—did not influence ICD. Conclusions: This 1‐year, postoperative follow‐up study showed ICD regression and dopaminergic drug reduction with optimal position of the active contacts within the subthalamic nucleus. Whereas patients with PD with preoperative ICD were prone to postoperative apathy, we also showed that those with preoperative apathy had a higher risk to experience postoperative de novo ICD, further highlighting the meaningful influence of postoperative management of dopaminergic medication on outcome and the continuum between apathy and ICD. © 2020 International Parkinson and Movement Disorder Society [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. The supplementary motor area modulates interhemispheric interactions during movement preparation
- Author
-
Welniarz, Quentin, primary, Gallea, Cécile, additional, Lamy, Jean‐Charles, additional, Méneret, Aurélie, additional, Popa, Traian, additional, Valabregue, Romain, additional, Béranger, Benoît, additional, Brochard, Vanessa, additional, Flamand‐Roze, Constance, additional, Trouillard, Oriane, additional, Bonnet, Cécilia, additional, Brüggemann, Norbert, additional, Bitoun, Pierre, additional, Degos, Bertrand, additional, Hubsch, Cécile, additional, Hainque, Elodie, additional, Golmard, Jean‐Louis, additional, Vidailhet, Marie, additional, Lehéricy, Stéphane, additional, Dusart, Isabelle, additional, Meunier, Sabine, additional, and Roze, Emmanuel, additional
- Published
- 2019
- Full Text
- View/download PDF
40. Antisaccade, a predictive marker for freezing of gait in Parkinson's disease and gait/gaze network connectivity.
- Author
-
Gallea, Cécile, Wicki, Benoit, Ewenczyk, Claire, Rivaud-Péchoux, Sophie, Yahia-Cherif, Lydia, Pouget, Pierre, Vidailhet, Marie, and Hainque, Elodie
- Subjects
PARKINSON'S disease ,FREEZING ,FUNCTIONAL magnetic resonance imaging ,GAZE ,FUNCTIONAL connectivity - Abstract
Freezing of gait is a challenging sign of Parkinson's disease associated with disease severity and progression and involving the mesencephalic locomotor region. No predictive factor of freezing has been reported so far. The primary objective of this study was to identify predictors of freezing occurrence at 5 years. In addition, we tested whether functional connectivity of the mesencephalic locomotor region could explain the oculomotor factors at baseline that were predictive of freezing onset. We performed a prospective study investigating markers (parkinsonian signs, cognitive status and oculomotor recordings, with a particular focus on the antisaccade latencies) of disease progression at baseline and at 5 years. We identified two groups of patients defined by the onset of freezing at 5 years of follow-up; the 'Freezer' group was defined by the onset of freezing in the ON medication condition during follow-up (n = 17), while the 'non-Freezer' group did not (n = 8). Whole brain resting-state functional MRI was recorded at baseline to determine how antisaccade latencies were associated with connectivity of the mesencephalic locomotor region networks in patients compared to 25 age-matched healthy volunteers. Results showed that, at baseline and compared to the non-Freezer group, the Freezer group had equivalent motor or cognitive signs, but increased antisaccade latencies (P = 0.008). The 5-year course of freezing of gait was correlated with worsening antisaccade latencies (P = 0.0007). Baseline antisaccade latencies was also predictive of the freezing onset (χ2 = 0.008). Resting state connectivity of mesencephalic locomotor region networks correlated with (i) antisaccade latency differently in patients and healthy volunteers at baseline; and (ii) the further increase of antisaccade latency at 5 years. We concluded that antisaccade latency is a predictive marker of the 5-year onset of freezing of gait. Our study suggests that functional networks associated with gait and gaze control are concurrently altered during the course of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. Personality dimensions of patients can change during the course of parkinson's disease.
- Author
-
Boussac, Mathilde, Arbus, Christophe, Dupouy, Julia, Harroch, Estelle, Rousseau, Vanessa, Croiset, Aurélie, Ory-Magne, Fabienne, Rascol, Olivier, Moreau, Caroline, Rolland, Anne-Sophie, Maltête, David, Rouaud, Tiphaine, Meyer, Mylène, Drapier, Sophie, Giordana, Bruno, Anheim, Mathieu, Hainque, Elodie, Jarraya, Béchir, Benatru, Isabelle, and Auzou, Nicolas
- Subjects
PARKINSON'S disease ,DEEP brain stimulation ,DOPAMINERGIC neurons ,PERSONALITY ,PERSONALITY studies - Abstract
Background: Studies assessing personality dimensions by the "Temperament and Character Inventory" (TCI) have previously found an association between Parkinson's disease (PD) and lower Novelty Seeking and higher Harm Avoidance scores. Here, we aimed to describe personality dimensions of PD patients with motor fluctuations and compare them to a normative population and other PD populations. Methods: All PD patients awaiting Deep Brain Stimulation (DBS) answered the TCI before neurosurgery. Their results were compared to those of historical cohorts (a French normative population, a de novo PD population, and a PD population with motor fluctuations). Results: Most personality dimensions of our 333 included PD patients with motor fluctuations who are candidates for DBS were different from those of the normative population and some were also different from those of the De Novo PD population, whereas they were similar to those of another population of PD patients with motor fluctuations. Conclusions: During the course of PD, personality dimensions can change in parallel with the development of motor fluctuations, either due to the evolution of the disease and/or dopaminergic treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson's Disease Patients (PSYCHO-STIM).
- Author
-
Boussac, Mathilde, Arbus, Christophe, Dupouy, Julia, Harroch, Estelle, Rousseau, Vanessa, Ory-Magne, Fabienne, Rascol, Olivier, Moreau, Caroline, Maltête, David, Rouaud, Tiphaine, Meyer, Mylène, Houvenaghel, Jean Francois, Marsé, Claire, Tranchant, Christine, Hainque, Elodie, Jarraya, Béchir, Ansquer, Solène, Bonnet, Marie, Belamri, Lhaouas, and Tir, Mélissa
- Subjects
PARKINSON'S disease ,DEEP brain stimulation ,QUALITY of life ,IMPULSE control disorders ,PATIENT education - Abstract
Parkinson's disease (PD) negatively affects patients' Quality of Life (QoL) which depends on both objective criteria such as physical health and subjective ones such as worries and norms according to personal believes. Therefore, QoL could be also associated to personality dimensions in chronic neurological diseases such as PD. Objective: Our objective was thus to study the potential association between personality dimensions and QoL in PD patients with motor fluctuations before Deep Brain Stimulation of the Sub-Thalamic Nucleus (DBS-STN). Methods: Data were obtained from the French multicentric cohort study Predi-Stim. All PD patients awaiting DBS-STN and responding to the inclusion criteria at the time of the study were included. All participants answered the "Temperament and Character Inventory" (TCI) and the PDQ-39 before surgery. Analyses were made using adjusted univariate generalized linear regression models to evaluate a potential association between TCI dimensions and PDQ-39 scores. Results: Three hundred thirty-three consecutive patients were included. The temperament Harm Avoidance was negatively associated with QoL (p = 1e-4, R
2 = 0.33), whereas the character Self-Directedness was positively associated with mental component of QoL (p = 2e-4, R2 = 0.33) in PD patients with motor fluctuations awaiting DBS-STN. Conclusions: PD patients with motor fluctuations, with lower Harm Avoidance and higher Self-Directedness scores have the best QoL mainly at an emotional and social level. Therapeutic education of these PD patients focusing on their personal resources may thus be important to improve their well-being. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
43. Long‐term GPi‐DBS improves motor features in myoclonus‐dystonia and enhances social adjustment
- Author
-
Kosutzka, Zuzana, primary, Tisch, Stephen, additional, Bonnet, Cecilia, additional, Ruiz, Marta, additional, Hainque, Elodie, additional, Welter, Marie‐Laure, additional, Viallet, Francois, additional, Karachi, Carine, additional, Navarro, Soledad, additional, Jahanshahi, Marjan, additional, Rivaud‐Pechoux, Sophie, additional, Grabli, David, additional, Roze, Emmanuel, additional, and Vidailhet, Marie, additional
- Published
- 2018
- Full Text
- View/download PDF
44. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood
- Author
-
Hainque, Elodie, primary, Caillet, Samantha, additional, Leroy, Sandrine, additional, Flamand-Roze, Constance, additional, Adanyeguh, Isaac, additional, Charbonnier-Beaupel, Fanny, additional, Retail, Maryvonne, additional, Le Toullec, Benjamin, additional, Atencio, Mariana, additional, Rivaud-Péchoux, Sophie, additional, Brochard, Vanessa, additional, Habarou, Florence, additional, Ottolenghi, Chris, additional, Cormier, Florence, additional, Méneret, Aurélie, additional, Ruiz, Marta, additional, Doulazmi, Mohamed, additional, Roubergue, Anne, additional, Corvol, Jean-Christophe, additional, Vidailhet, Marie, additional, Mochel, Fanny, additional, and Roze, Emmanuel, additional
- Published
- 2017
- Full Text
- View/download PDF
45. A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome
- Author
-
Gras, Domitille, primary, Cousin, Christelle, additional, Kappeler, Caroline, additional, Fung, Cheuk‐Wing, additional, Auvin, Stéphane, additional, Essid, Nouha, additional, Chung, Brian Hy, additional, Da Costa, Lydie, additional, Hainque, Elodie, additional, Luton, Marie‐Pierre, additional, Petit, Vincent, additional, Vuillaumier‐Barrot, Sandrine, additional, Boespflug‐Tanguy, Odile, additional, Roze, Emmanuel, additional, and Mochel, Fanny, additional
- Published
- 2017
- Full Text
- View/download PDF
46. Teaching Video NeuroImages: Hyperekplexia
- Author
-
Mariani, Louise-Laure, primary, Hainque, Elodie, additional, Mongin, Marie, additional, Apartis, Emmanuelle, additional, and Roze, Emmanuel, additional
- Published
- 2017
- Full Text
- View/download PDF
47. Alternating Upper Limb Monoplegia due to ATP1A3 Mutation
- Author
-
Delorme, Cécile, primary, Hainque, Elodie, additional, and Roze, Emmanuel, additional
- Published
- 2017
- Full Text
- View/download PDF
48. A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia
- Author
-
Hainque, Elodie, Mutez, Eugénie, Doe De Maindreville, Anne, Lebouvier, Thibaud, Hubsch, Cécile, Degos, Bertrand, Bonnet, Cécilia, Grabli, David, Legrand, André Pierre, Méneret, Aurélie, Azulay, Jean Philippe, Vidailhet, Marie, Bissery, Anne, Zahr, Noël, Clot, Fabienne, Mallet, Alain, Dupont, Sophie, Apartis, Emmanuelle, Corvol, Jean-Christophe, Roze, Emmanuel, Cozic, Nathalie, Charbonnier-Beaupel, Fanny, Thobois, Stéphane, Tranchant, Christine, Brochard, Vanessa, Glibert, Gerald, Drapier, Sophie, Hainque, Elodie, Mutez, Eugénie, Doe De Maindreville, Anne, Lebouvier, Thibaud, Hubsch, Cécile, Degos, Bertrand, Bonnet, Cécilia, Grabli, David, Legrand, André Pierre, Méneret, Aurélie, Azulay, Jean Philippe, Vidailhet, Marie, Bissery, Anne, Zahr, Noël, Clot, Fabienne, Mallet, Alain, Dupont, Sophie, Apartis, Emmanuelle, Corvol, Jean-Christophe, Roze, Emmanuel, Cozic, Nathalie, Charbonnier-Beaupel, Fanny, Thobois, Stéphane, Tranchant, Christine, Brochard, Vanessa, Glibert, Gerald, and Drapier, Sophie
- Abstract
Objective: To evaluate the efficacy and safety of zonisamide in patients with myoclonus-dystonia. Methods: We conducted a randomized, double-blind, placebo-controlled crossover trial of zonisamide (300 mg/d) in 24 patients with myoclonus-dystonia. Each treatment period consisted of a 6-week titration phase followed by a 3-week fixed-dose phase. The periods were separated by a 5-week washout period. The co-primary outcomes were action myoclonus severity (section 4 of the Unified Myoclonus Rating Scale [UMRS 4]) and myoclonus-related functional disability (UMRS 5). Secondary outcomes included dystonia severity, assessed with the movement and disability subscales of the Burke-Fahn-Marsden-Dystonia Rating Scale (BFM), the Clinical Global Impression-Improvement scale (CGI), and safety measures. Wilcoxon signed-rank tests for paired data were used to analyze treatment effects. Results: Twenty-three patients (11 men, 12 women) were analyzed in the intention-to-treat analysis. Zonisamide significantly improved both action myoclonus (median improvement [95% confidence limits] -5 [-9.25 to -1.44], p 0.003) and myoclonus-related functional disability (median improvement [95% confidence limits] -2 [-2.58 to -2.46], p 0.007) compared to placebo. Zonisamide also significantly improved dystonia (BFM movement) compared to placebo (median improvement [95% confidence limits] -3 [-8.46 to 0.03], p 0.009). No difference was found between zonisamide and placebo with respect to the CGI (median improvement [95% confidence limits] -1 [-1.31 to 0.09], p 0.1). Zonisamide was well-tolerated. Conclusions: Zonisamide is well-tolerated and effective on the motor symptoms of myoclonus-dystonia. Classification of evidence: This study provides Class I evidence that zonisamide improves myoclonus and related disability in patients with myoclonus-dystonia., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2016
49. Tremor-Like Myoclonus Associated with Klinefelter Syndrome in a Child
- Author
-
Gras, Domitille, primary, Hainque, Elodie, primary, Fabre-Teste, Jennifer, primary, Apartis, Emmanuelle, primary, and Roze, Emmanuel, additional
- Published
- 2016
- Full Text
- View/download PDF
50. A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia
- Author
-
Hainque, Elodie, primary, Vidailhet, Marie, additional, Cozic, Nathalie, additional, Charbonnier-Beaupel, Fanny, additional, Thobois, Stéphane, additional, Tranchant, Christine, additional, Brochard, Vanessa, additional, Glibert, Gérald, additional, Drapier, Sophie, additional, Mutez, Eugénie, additional, Doe De Maindreville, Anne, additional, Lebouvier, Thibaud, additional, Hubsch, Cécile, additional, Degos, Bertrand, additional, Bonnet, Cécilia, additional, Grabli, David, additional, Legrand, André-Pierre, additional, Méneret, Aurélie, additional, Azulay, Jean-Philippe, additional, Bissery, Anne, additional, Zahr, Noël, additional, Clot, Fabienne, additional, Mallet, Alain, additional, Dupont, Sophie, additional, Apartis, Emmanuelle, additional, Corvol, Jean-Christophe, additional, and Roze, Emmanuel, additional
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.